Cigna (CI) to Reaffirm Outlook at Upcoming Investor/Analyst Meetings
Get Alerts CI Hot Sheet
Price: $277.51 +1.13%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interest: -4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interest: -4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Beginning on February 29, 2012 and through the balance of the week, Cigna (NYSE: CI) officials expect to participate in meetings and discussions with investors and analysts, including the Citi 2012 Global Health Care Conference. During these meetings, Company officials expect to reaffirm consolidated adjusted income from operations estimates for full year 2012, which remain in the range of $1.46 billion to $1.57 billion. The Company’s full year 2012 financial outlook assumes break-even results for the Company’s Guaranteed Minimum Death Benefits business (also known as “VADBe”) for full year 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
GuidanceRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share